Market Closed

IONS
Ionis Pharmaceuticals
$ 29.06
6.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Ionis Pharmaceuticals News

Latest Ionis Pharmaceuticals Stock News & IONS Headlines

Wolf Popper LLP Announces Investigation on Behalf of Ionis Pharmaceuticals, Inc. Investors
2 days ago | globenewswire.com
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Ionis Pharmaceuticals, Inc. (IONS)
3 days ago | globenewswire.com
Here's Why Ionis Pharmaceuticals' Stock is Down 28.5% Post Q3 Earnings
3 days ago | zacks.com
Ionis Pharmaceuticals (NASDAQ:IONS) Stock Falls 7.3% Following Analyst Downgrade
4 days ago | defenseworld.net
Wolf Popper LLP Announces Investigation on Behalf of Ionis Pharmaceuticals, Inc. Investors
4 days ago | globenewswire.com
Ionis to present at upcoming investor conferences
5 days ago | businesswire.com
Ionis: 3 Key Takeaways for Long-Term Investors
5 days ago | fool.com
Ionis Pharmaceuticals: Q3 Triggers The Latest Selloff On Tryngolza Disappointment
5 days ago | seekingalpha.com
Ionis Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ionis Pharmaceuticals (IONS)
5 days ago | prnewswire.com
Ionis Pharmaceuticals, Inc. (IONS) Q3 2026 Earnings Call Transcript
5 days ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

IONS
Ionis Pharmaceuticals
$ 29.06
6.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago